NeoGenomics Inc (NEO)

Debt-to-equity ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 902,339 908,210 915,884 923,410 941,537 947,428 956,192 974,462 998,023 1,012,990 1,043,520 1,075,000 1,108,280 1,137,240 1,148,360 843,714 694,294 666,363 654,229 505,043
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $902,339K
= 0.00

The debt-to-equity ratio of NeoGenomics Inc has remained constant at 0.00 throughout the periods from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt to finance its operations and growth, relying solely on equity financing. A debt-to-equity ratio of 0.00 signifies a very low risk of financial distress related to leverage, as there is no debt in the capital structure to amplify losses in case of downturns. This strategy can provide stability and financial flexibility but may also limit potential returns on investment. Overall, NeoGenomics Inc's consistent 0.00 debt-to-equity ratio suggests a conservative and financially secure capital structure.